Traws Pharma shareholders approve 1.5M share increase to incentive plan and elect directors

Traws Pharma, Inc.

Stockholders approved amendment to 2021 Incentive Compensation Plan, increasing authorized shares by 1,500,000 and extending term to November 20, 2035.
Seven directors elected: Iain Dukes, Werner Cautreels, Trafford Clarke, John Leaman, Nikolay Savchuck, M. Teresa Shoemaker, Jack E. Stover.
Advisory vote on executive compensation approved; company will hold such votes every two years, next at 2027 annual meeting.
Ratification of KPMG as independent auditor for FY2025 approved with 3,350,178 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.